On Aug 31, 2021 ARS Pharmaceuticals closed a Series D round and raised $55,000,000 from Deerfield Management, RA Capital Management, SR One, featuring lead investors […]
Series A – Versanis Bio
On Aug 31, 2021 Versanis Bio closed a Series A round and raised $70,000,000 from Aditum Bio, Atlas Venture, Medicxi Ventures, featuring lead investors Atlas […]
Series D – ARS Pharmaceuticals
On Aug 31, 2021 ARS Pharmaceuticals closed a Series D round and raised $55,000,000 from Deerfield Management, RA Capital Management, SR One, featuring lead investors […]
Series B – Neurogastrx
On Aug 26, 2021 Neurogastrx closed a Series B round and raised $60,000,000 from 5AM Ventures, Marshall Wace, OrbiMed, RTW Investments LLC, Samsara BioCapital, venBio […]
Series B – Neurogastrx
On Aug 26, 2021 Neurogastrx closed a Series B round and raised $60,000,000 from 5AM Ventures, Marshall Wace, OrbiMed, RTW Investments LLC, Samsara BioCapital, venBio […]
Series B – Cardior Pharmaceuticals
On Aug 25, 2021 Cardior Pharmaceuticals closed a Series B round and raised €64,000,000 from BioMedPartners, Bristol Myers Squibb, coparion, Fund+, Hadean Ventures, High-Tech Grunderfonds, […]
Series B – Cardior Pharmaceuticals
On Aug 25, 2021 Cardior Pharmaceuticals closed a Series B round and raised €64,000,000 from BioMedPartners, Bristol Myers Squibb, coparion, Fund+, Hadean Ventures, High-Tech Grunderfonds, […]
Intersect ENT acquired by Medtronic
Aug 6, 2021 Medtronic has entered into an agreement to acquire Intersect ENT in a $1,100,000,000 deal. Medtronic based at Minneapolis, Minnesota, United States. “Компанія […]
AbGel acquired by Healthium Medtech
Aug 3, 2021 Healthium Medtech has entered into an agreement to acquire AbGel . Healthium Medtech based at Bengaluru, Karnataka, India. “Healthium MedTech provide ranges […]
Series A – Mixlab
On Aug 2, 2021 Mixlab closed a Series A round and raised $20,000,000 from Brand Foundry Ventures, Global Founders Capital, Lakehouse Ventures, Monogram Capital Partners, […]
